Resultados de la búsqueda

Devesa A, Fuster V, García-Lunar I, Oliva B, García-Alvarez A, Moreno-Arciniegas A, Vazirani R, Pérez-Herreras C, Marina P, Bueno H, Fernández-Friera L, Fernández-Ortiz A, Sanchez-Gonzalez J, Ibanez B. Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors. JACC Cardiovasc Imaging (2024) S1936-878X:00342-5.
Link to the full text in Repisalud

Makhlin I, Demissei BG, D'Agostino R, Hundley WG, Baleanu-Gogonea C, Wilcox NS, Chen A, Smith AM, O'Connell NS, Januzzi JL, Lesser GJ, Scherrer-Crosbie M, Ibáñez B, Tang WHW, Ky B. Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial. CLIN CANCER RES (2024) 30:2370-2376
Link to the full text in Repisalud

Devesa A, Rashed E, Moss N, Robson PM, Pyzik R, Roldan J, Taimur S, Rana MM, Ashley K, Young A, Patel G, Mahmood K, Mitter SS, Lala A, Barghash M, Fox A, Correa A, Pirlamarla P, Contreras J, Parikh A, Mancini D, Jacobi A, Ghesani N, Gavane SC, Ghesani M, Itagaki S, Anyanwu A, Fayad ZA, Trivieri MG. 18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications J Heart Lung Transplant (2024) 43:529-538

Takaoka M, Tadross JA, Al-Hadithi ABAK, Zhao X, Villena-Gutiérrez R, Tromp J, Absar S, Au M, Harrison J, Coll AP, Marciniak SJ, Rimmington D, Oliver E, Ibáñez B, Voors AA, O'Rahilly S, Mallat Z, Goodall JC. GDF15 antagonism limits severe heart failure and prevents cardiac cachexia. Cardiovasc Res (2024) 120:2249-2260.

Fernández-Tocino M, Pun-Garcia A, Gómez M, Clemente-Moragón A, Oliver E, Villena-Gutierrez R, Trigo-Anca S, Díaz-Guerra A, Sanz-Rosa D, Prados B, Del Campo L, Andrés V, Fuster V, de la Pompa JL, Cádiz L, Ibañez B. BETA-3 Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia-reperfusion injury. Basic Res Cardiol (2024) 119:773-794
Link to the full text in Repisalud

Moreno-Arciniegas A, Cádiz L, Galán-Arriola C, Clemente-Moragón A, Ibáñez B. Cardioprotection strategies for anthracycline cardiotoxicity. Basic Res Cardiol (2024) 120:71-90

Kleinbongard P, Arriola CG, Badimon L, Crisostomo V, Giricz Z, Gyöngyösi M, Heusch G, Ibanez B, Kiss A, de Kleijn DPV, Podesser BK, Carracedo RR, Rodríguez-Sinovas A, Ruiz-Meana M, Sanchez Margallo FM, Vilahur G, Zamorano JL, Zaragoza C, Ferdinandy P, Hausenloy DJ. he IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning. Basic Res Cardiol (2024) 119:893-909
Link to the full text in Repisalud

Ramos-Prada A, Redondo-Rodríguez A, Roca-Luque I, Porta-Sánchez A, Ter Bekke RMA, Quintanilla JG, Sánchez-González J, Peinado R, Merino JL, Cluitmans M, Holtackers RJ, Marina-Breysse M, Galán-Arriola C, Enríquez-Vázquez D, Vázquez-Calvo S, Alfonso-Almazán JM, Pizarro G, Ibáñez B, González-Ferrer JJ, Salgado-Aranda R, Cañadas-Godoy V, Calvo D, Pérez-Villacastín J, Pérez-Castellano N, Filgueiras-Rama D. Novel systematic processing of cardiac magnetic resonance imaging identifies target regions associated with infarct-related ventricular tachycardia. Europace (2024) 26:euae244

Devesa A, Robson PM, Cangut B, Vazirani R, Vergani V, LaRocca G, Romero-Daza AM, Liao S, Azoulay LD, Pyzik R, Fayad RA, Jacobi A, Abgral R, Morgenthau AS, Miller MA, Fayad ZA, Trivieri MG. Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis. Heart Rhythm (2024) S1547-5271:03301-0

Augé-Bailac F, Rosselló X. Value of the Life's Essential 8 score in cardiovascular health and mortality Rev Esp Cardiol (2024) 77:381-382
Link to the full text in Repisalud